248 related articles for article (PubMed ID: 30872410)
21. Microarray technology to investigate genes associated with papillary thyroid carcinoma.
Zhu X; Yao J; Tian W
Mol Med Rep; 2015 May; 11(5):3729-33. PubMed ID: 25586635
[TBL] [Abstract][Full Text] [Related]
22. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis.
Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J
World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma.
Reyes I; Reyes N; Suriano R; Iacob C; Suslina N; Policastro A; Moscatello A; Schantz S; Tiwari RK; Geliebter J
Cancer Biomark; 2019; 24(1):71-83. PubMed ID: 30614796
[TBL] [Abstract][Full Text] [Related]
24. Competing endogenous RNA regulatory network in papillary thyroid carcinoma.
Chen S; Fan X; Gu H; Zhang L; Zhao W
Mol Med Rep; 2018 Jul; 18(1):695-704. PubMed ID: 29767230
[TBL] [Abstract][Full Text] [Related]
25. Identification of Genes Associated with Papillary Thyroid Carcinoma (PTC) for Diagnosis by Integrated Analysis.
Li WB; Zhou J; Xu L; Su XL; Liu Q; Pang H
Horm Metab Res; 2016 Apr; 48(4):226-31. PubMed ID: 26756467
[TBL] [Abstract][Full Text] [Related]
26. Naive and regulatory B-cell transcription patterns guide the increased risk of papillary thyroid carcinoma in obesity.
Yu Z; Xu Z; Li S; Tian Z; Yuan J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):118-126. PubMed ID: 38678617
[TBL] [Abstract][Full Text] [Related]
27. Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
Tang X; Huang X; Wang D; Yan R; Lu F; Cheng C; Li Y; Xu J
Gene; 2019 Jul; 704():142-148. PubMed ID: 30965127
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q
J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873
[TBL] [Abstract][Full Text] [Related]
29. Investigating the mechanisms of papillary thyroid carcinoma using transcriptome analysis.
Qiu J; Zhang W; Xia Q; Liu F; Zhao S; Zhang K; Chen M; Zang C; Ge R; Liang D; Sun Y
Mol Med Rep; 2017 Nov; 16(5):5954-5964. PubMed ID: 28849102
[TBL] [Abstract][Full Text] [Related]
30. Identification of differentially expressed genes and signaling pathways in papillary thyroid cancer: a study based on integrated microarray and bioinformatics analysis.
Sun T; Guan Q; Wang Y; Qian K; Sun W; Ji Q; Wu Y; Guo K; Xiang J
Gland Surg; 2021 Feb; 10(2):629-644. PubMed ID: 33708546
[TBL] [Abstract][Full Text] [Related]
31. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma.
Han J; Chen M; Wang Y; Gong B; Zhuang T; Liang L; Qiao H
Sci Rep; 2018 Jul; 8(1):9912. PubMed ID: 29967488
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
[TBL] [Abstract][Full Text] [Related]
33. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
34. Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles.
Wei S; Yun X; Ruan X; Wei X; Zheng X; Gao M
Oncol Lett; 2019 Dec; 18(6):6670-6678. PubMed ID: 31814850
[TBL] [Abstract][Full Text] [Related]
35. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy.
Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR
Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887
[TBL] [Abstract][Full Text] [Related]
36. Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis.
Liu Y; Chen TY; Yang ZY; Fang W; Wu Q; Zhang C
J Transl Med; 2020 Apr; 18(1):170. PubMed ID: 32299435
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of lncRNA-mediated ceRNA network in papillary thyroid cancer.
Sun Y; Dai WR; Xia N
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10003-10014. PubMed ID: 33090405
[TBL] [Abstract][Full Text] [Related]
38. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
39. Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis.
Wei J; Wang Y; Shi K; Wang Y
Biomed Res Int; 2020; 2020():8959210. PubMed ID: 32258155
[TBL] [Abstract][Full Text] [Related]
40. Low expression of
Yang L; Zhang X; Zhang J; Liu Y; Ji T; Mou J; Fang X; Wang S; Chen J
Future Oncol; 2022 Jan; 18(3):333-348. PubMed ID: 34756116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
